FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to compounds with structural formulas
,
as follows and their stereoisomers, wherein Y represents
or
and using them for an agent for treating and/or preventing glaucoma and/or ocular hypertension.
EFFECT: treating and/or preventing glaucoma and/or ocular hypertension.
7 cl, 32 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SUBSTITUTED GAMMA-LACTAMS AS THERAPEUTIC AGENTS | 2006 |
|
RU2412933C2 |
| THERAPEUTIC SUBSTITUTED LACTAMS | 2008 |
|
RU2481342C9 |
| SUBSTITUTED CYCLOPENTANS POSSESSING PROSTAGLANDIN ACTIVITY | 2008 |
|
RU2481339C2 |
| COMPOUNDS AND METHODS OF INHIBITING INTERACTION OF BCL PROTEINS WITH BINDING COMPONENTS | 2005 |
|
RU2416606C2 |
| P38 INHIBITORS AND APPLICATION METHODS | 2004 |
|
RU2357957C2 |
| NOVEL BICYCLIC DERIVATIVES | 2020 |
|
RU2830113C2 |
| SUBSTITUTED CYCLOPENTANES, POSSESSING PROSTAGLANDIN ACTIVITY | 2009 |
|
RU2505530C2 |
| MODULATORS OF ATP-BINDING TRANSPORTERS | 2010 |
|
RU2552353C2 |
| THERAPEUTIC SUBSTITUTED CYCLOPENTANES | 2009 |
|
RU2501789C2 |
| NON-ANNELATED TYOPHENYLAMIDS AS INHIBITORS OF FATTY ACIDS FABP 4 AND / OR 5 BINDING PROTEINS | 2013 |
|
RU2647587C2 |
Authors
Dates
2015-02-27—Published
2009-04-22—Filed